Companies · Medical Devices

Halo Diagnostics Llc

ANN ARBOR · Medical Devices · refined from filed group “Other Health Care

Diligence memoA one-page analyst read on Halo Diagnostics Llc — recommendation, valuation, rhythm, risks.
$488K
Total raised · real
1
Rounds
Latest step-up
Top 71%
Sector rank · raised
Pre-Seed
Latest stage · inferred · Thu May 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)

Halo Diagnostics Llc looks over-valued against its niche peers and is dormant on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the medical devices sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Over-valued
  • Modeled value is 2.44× the median modeled value of Pre-Seed Medical Devices companies in 2019–2021 (26 peers) — value vs value, same stage and era.
Dormant
  • Last raise 7.1 yr ago; this sector typically re-raises about every 16 months.
  • Only one round on record and long silent — often defunct, acquired, or gone quiet.

Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.

Issuer-vehicle patternmedium confidence

Halo Diagnostics Llc behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.

Issuer structure
Company-like
No recurring-offering pattern strong enough to override normal financing interpretation.
Lifecycle
7.1 yr record
Peak capital year was 2019 with $488K across 1 filings.
Market position
ahead of 30% of Medical Devices peers
Capital scale is ahead of 30% of Medical Devices peers; modeled value is above 59% of peers by modeled value. Large capital with mid-pack modeled value can signal an issuer/program profile rather than operating-company growth.
Valuation reliability
Normal applicability
Stage/dilution valuation models are weakest when the issuer is broad-sector, recurring, or vehicle-like.
Operating evidence
Sparse
No clear CEO/founder/principal role is surfaced, so operating-company confidence is lower.
Data quality
Consistent
Canonical totals and visible filing detail are broadly aligned.
What triggered this
  • Legal name looks like an issuer vehicle rather than a product company.
  • No clearly named CEO/founder/principal role in the public records surfaced here.
  • No verified homepage on the profile yet.
  • Capital program peaked in 2019: $488K across 1 filings.
  • Largest single filing was $488K on 2019-05-30.
How to read the page
  • Read this less like a startup funding journey and more like a capital-raising program.
  • Stage-based valuation and peer labels have lower applicability for this pattern.
  • The more important signal is lifecycle: repeated filings ended years ago, so current activity needs outside confirmation.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Medical Devices

Halo Diagnostics Llc is one of 233 Medical Devices companies tracked from ANN ARBOR. By capital raised it ranks in the long tail (ahead of 30% of sector peers), and mid-pack by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

medical-devices

As reported in public records reported — not modeled.

US
Jurisdiction
Rule 506(b)
Reg D exemption
2
Investors (latest)
2019
Year incorporated
2019-05-30
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$5.0M$10M$15M$20MPre-Seed · 2019-05-30 Raised $488K (real) Modeled valuation $18M (est)$488K$18MPre-Seed2019

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Pre-Seed$488K · 2019

Stages are modeled from round size (public records carry no series label). Ladder is contiguous — every modeled rung has a record.

Modeled valuation trajectory
$18.0M
Base estimate est.
$293K
Conservative case
$203.9M
Upside case
$2.7M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Pre-Seeda round under $1.0M). Valuation is modeled from stage benchmarks scaled by the medical devices sector profile. Directional, not a quoted figure.

Not enough modeled valuation points to chart a trajectory.

Model inputs · modeled:benchmark-stage-stepup-v1
18%
Dilution assumption
Implied ownership sold in the financing.
27%
Survival probability
11% low · 50% high
1.71×/yr
Annual markup
2.31×/yr upside case
6.0 yr
Elapsed time used
7.1 yr actual, capped for stale marks
medical devices
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
Avg between rounds
Capital velocity
7.1 yr
On record since
2019
First round
1
Rounds on file
How it compares to the market

Benchmarked against 233 companies in Medical Devices. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 0.2× of median
This company$488K
Sector median$2.6M
Latest round — vs other Pre-Seed rounds in sector (real $, this stage) 1.6× above median
This company$488K
Sector median$296K
Modeled value — vs sector median (estimate, all stages) 1.2× above median
This company$18.0M
Sector median$15.4M

Raised more than 30% of sector peers (real $). Modeled value above 59% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Pre-Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #5 of 26.

This companyCohort peer
$1.0M$10.0M$100.0M$100K$1.0M$10.0MCapital raised (log)Augustine Surgical, Inc. · Pre-Seed Raised $1.5M · modeled $36.9M (est)White Mountain Surgical Partners, LLC · Pre-Seed Raised $841K · modeled $31.0M (est)Irving Specialists Surgical Center LLC · Pre-Seed Raised $800K · modeled $27.6M (est)Grand Parkway Surgical Institute LLC · Pre-Seed Raised $555K · modeled $20.4M (est)West Texas Surgical Services, LLC · Pre-Seed Raised $481K · modeled $12.0M (est)Riverside Surgical Center of Meadowlands, LLC · Pre-Seed Raised $978K · modeled $11.2M (est)Franklin Surgical Center, LLC · Pre-Seed Raised $1.0M · modeled $9.2M (est)Osage ArkMo Surgical Services LLC · Pre-Seed Raised $819K · modeled $8.6M (est)Direct Surgical Services LLC · Pre-Seed Raised $461K · modeled $8.4M (est)Accessible Diagnostics LLC · Pre-Seed Raised $719K · modeled $8.1M (est)Auricle, Inc. · Pre-Seed Raised $350K · modeled $8.1M (est)Halo Diagnostics Llc (this company) Raised $488K · modeled $18.0M (est)Halo Diagnostics Llc
CompanyStageRaised · realValue · estvs peer med.
Augustine Surgical, Inc.Pre-Seed$1.5M$36.9M5.00×
White Mountain Surgical Partners, LLCPre-Seed$841K$31.0M4.21×
Irving Specialists Surgical Center LLCPre-Seed$800K$27.6M3.74×
Grand Parkway Surgical Institute LLCPre-Seed$555K$20.4M2.77×
Halo Diagnostics Llc this companyPre-Seed$488K$18.0M2.44×
West Texas Surgical Services, LLCPre-Seed$481K$12.0M1.62×
Riverside Surgical Center of Meadowlands, LLCPre-Seed$978K$11.2M1.52×
Franklin Surgical Center, LLCPre-Seed$1.0M$9.2M1.25×
Osage ArkMo Surgical Services LLCPre-Seed$819K$8.6M1.17×
Direct Surgical Services LLCPre-Seed$461K$8.4M1.13×
Accessible Diagnostics LLCPre-Seed$719K$8.1M1.10×
Auricle, Inc.Pre-Seed$350K$8.1M1.09×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Pre-Seed$488K2019-05-30$2.7M$18.0M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Pre-Seed$488K2019-05-30
    • First recorded raise — entered as Pre-Seed.
    • 2 investors on this round.
Intelligence
Modeled next raise
$781K
Modeled next size est.range $508K$1.2M
Last step-up
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
Ryan Waddington4 other2019-05
Brian Axe2 other2019-05
ARAM CAMPEAU2019-05
MICHAEL UHL2019-05
Registry & provenance

Halo Diagnostics Llc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1777080
SEC CIK
2019
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
West Texas Surgical Services, LLCMedical DevicesPre-Seed$481K$12.0Msame sector · same stage
First Coast Surgical Services LLCMedical DevicesPre-Seed$470K$9.6Msame sector · same stage
Illumix Surgical Canada Inc.Medical DevicesPre-Seed$468K$196Ksame sector · same stage
Prime Surgical Center of Torrance, LLCMedical DevicesPre-Seed$462K$17.0Msame sector · same stage
Direct Surgical Services LLCMedical DevicesPre-Seed$461K$8.4Msame sector · same stage
East Valley Surgical Services LLCMedical DevicesPre-Seed$438K$3.5Msame sector · same stage
Upland Outpatient Surgical Center, L.P.Medical DevicesPre-Seed$554K$710Ksame sector · same stage
Derry Surgical Center, LLCMedical DevicesPre-Seed$430K$764Ksame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Magnolia Diagnostics, LLCMedical DevicesPre-Seed$34.5M86%
Accessible Diagnostics LLCMedical DevicesPre-Seed$8.1M86%
Emerge Diagnostics, IncMedical DevicesSeries A$688K86%
Burst Diagnostics, Inc.Medical DevicesSeed$14.0M86%
Empowered Diagnostics, LLCMedical DevicesSeed$27.8M85%
Sword Diagnostics IncMedical DevicesSeed$45.2M85%
Biovision Diagnostics LLCMedical DevicesSeed$47.6M85%
Alert Mobile Diagnostics, LLCMedical DevicesPre-Seed$21.2M85%
Frequently asked
How much funding has Halo Diagnostics Llc raised?
Halo Diagnostics Llc has raised approximately $488K in disclosed capital across 1 recorded financing round, aggregated from public filings.
What is Halo Diagnostics Llc's estimated valuation?
Provath's modeled valuation for Halo Diagnostics Llc is approximately $18.0M (modeled range $293K–$203.9M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Halo Diagnostics Llc at?
Halo Diagnostics Llc's latest modeled financing stage is Pre-Seed. Its most recent recorded round closed around Thu May 30.
What does Halo Diagnostics Llc do and where is it based?
Halo Diagnostics Llc operates in the Medical Devices sector, based in ANN ARBOR.
Explore related

See where Halo Diagnostics Llc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Halo Diagnostics Llc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.